availability string | days_in_shortage string | derived_fields list | dosage_form string | generic_name string | id string | initial_posting_date string | manufacturer_name string | package_ndc string | source string | source_quote string | status string | therapeutic_category string | update_date string | url string | verified_fields list | related_info string | shortage_reason string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Available | 1768 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-0274-01 | 12/15/2021 | Pfizer Inc. | 0009-0274-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-0274-01", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Available" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0274-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1768 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-0280-02 | 12/15/2021 | Pfizer Inc. | 0009-0280-02 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-0280-02", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Available" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0280-02/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Limited Availability | 1768 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-0280-03 | 12/15/2021 | Pfizer Inc. | 0009-0280-03 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-0280-03", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Limited Availability", "related_info": "Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Ma... | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0280-03/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
Available | 1768 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-0280-51 | 12/15/2021 | Pfizer Inc. | 0009-0280-51 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-0280-51", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Available" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0280-51/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1768 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-0280-52 | 12/15/2021 | Pfizer Inc. | 0009-0280-52 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-0280-52", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Available" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0280-52/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1768 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-0306-02 | 12/15/2021 | Pfizer Inc. | 0009-0306-02 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-0306-02", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Available" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0306-02/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1768 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-0306-12 | 12/15/2021 | Pfizer Inc. | 0009-0306-12 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-0306-12", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Available" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0306-12/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1307 | [
"days_in_shortage"
] | Injection | Clindamycin Phosphate Injection | pfizer-inc-clindamycin-phosphate-injection-0009-0775-26 | 03/21/2023 | Pfizer Inc. | 0009-0775-26 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/21/2023", "package_ndc": "0009-0775-26", "generic_name": "Clindamycin Phosphate Injection", "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d", "contact_info": "800-533-4535", "availability":... | Current | Anti-Infective | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-clindamycin-phosphate-injection-0009-0775-26/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Unavailable | 1307 | [
"days_in_shortage"
] | Injection | Clindamycin Phosphate Injection | pfizer-inc-clindamycin-phosphate-injection-0009-0870-26 | 03/21/2023 | Pfizer Inc. | 0009-0870-26 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/21/2023", "package_ndc": "0009-0870-26", "generic_name": "Clindamycin Phosphate Injection", "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d", "contact_info": "800-533-4535", "availability":... | Current | Anti-Infective | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-clindamycin-phosphate-injection-0009-0870-26/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Next Delivery and Estimated Recovery: December 2028 | Demand increase for the drug |
Available | 1307 | [
"days_in_shortage"
] | Injection | Clindamycin Phosphate Injection | pfizer-inc-clindamycin-phosphate-injection-0009-0902-18 | 03/21/2023 | Pfizer Inc. | 0009-0902-18 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/21/2023", "package_ndc": "0009-0902-18", "generic_name": "Clindamycin Phosphate Injection", "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d", "contact_info": "800-533-4535", "availability":... | Current | Anti-Infective | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-clindamycin-phosphate-injection-0009-0902-18/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Limited Availability | 1768 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-3073-01 | 12/15/2021 | Pfizer Inc. | 0009-3073-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-3073-01", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Limited Availability", "related_info": "Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-3073-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026 | Demand increase for the drug |
Limited Availability | 1768 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-3073-03 | 12/15/2021 | Pfizer Inc. | 0009-3073-03 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-3073-03", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Limited Availability", "related_info": "Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: December 2026; Shortage per M... | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-3073-03/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
Unavailable | 1768 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-3073-22 | 12/15/2021 | Pfizer Inc. | 0009-3073-22 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-3073-22", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Unavailable", "related_info": "Next Delivery: October 2026; Estimated Recovery: December 2026" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-3073-22/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Next Delivery: October 2026; Estimated Recovery: December 2026 | Demand increase for the drug |
Unavailable | 1768 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-3073-23 | 12/15/2021 | Pfizer Inc. | 0009-3073-23 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-3073-23", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Unavailable", "related_info": "Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-3073-23/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
Limited Availability | 1768 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-3475-01 | 12/15/2021 | Pfizer Inc. | 0009-3475-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-3475-01", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Limited Availability", "related_info": "Limited Supply Available. Next Delivery and Estimated Recovery: December 2026" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-3475-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Limited Supply Available. Next Delivery and Estimated Recovery: December 2026 | Demand increase for the drug |
Limited Availability | 1768 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-3475-03 | 12/15/2021 | Pfizer Inc. | 0009-3475-03 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-3475-03", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Limited Availability", "related_info": "Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: March 2027; Shortage per Manu... | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-3475-03/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
Available | 1080 | [
"days_in_shortage"
] | Concentrate | Cromolyn Sodium Concentrate | mylan-specialty-a-viatris-company-cromolyn-sodium-concentrate-0037-0678-96 | 11/03/2023 | Mylan Specialty, a Viatris Company | 0037-0678-96 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Specialty,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "11/03/2023", "package_ndc": "0037-0678-96", "generic_name": "Cromolyn Sodium Concentrate", "contact_info": "(800) 796-9526", "availability": "Available" | Current | Pulmonary/Allergy | 10/05/2026 | https://referencesource.org/drug-shortage-duration-tracker/mylan-specialty-a-viatris-company-cromolyn-sodium-concentrate-0037-0678-96/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Unavailable | 2046 | [
"days_in_shortage"
] | Spray | Desmopressin Acetate Spray | ferring-desmopressin-acetate-spray-0053-6871-00 | 03/12/2021 | Ferring | 0053-6871-00 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Ferring%22+AND+generic_name%3A%22Desmopressin%20Acetate%20Spray%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/12/2021", "package_ndc": "0053-6871-00", "generic_name": "Desmopressin Acetate Spray", "contact_info": "888-337-7464", "availability": "Unavailable", "related_info": "Estimated recovery: TBD" | Current | Hematology | 05/01/2026 | https://referencesource.org/drug-shortage-duration-tracker/ferring-desmopressin-acetate-spray-0053-6871-00/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: TBD | Requirements related to complying with good manufacturing practices |
Limited Availability | 1192 | [
"days_in_shortage"
] | Capsule | Lisdexamfetamine Dimesylate Capsule | hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0370-25 | 07/14/2023 | Hikma Pharmaceuticals USA, Inc. | 0054-0370-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/14/2023", "package_ndc": "0054-0370-25", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Available on allocation" | Current | Psychiatry | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0370-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Available on allocation | Shortage of an active ingredient |
Limited Availability | 1192 | [
"days_in_shortage"
] | Capsule | Lisdexamfetamine Dimesylate Capsule | hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0371-25 | 07/14/2023 | Hikma Pharmaceuticals USA, Inc. | 0054-0371-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/14/2023", "package_ndc": "0054-0371-25", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Available on allocation" | Current | Psychiatry | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0371-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Available on allocation | Shortage of an active ingredient |
Limited Availability | 1192 | [
"days_in_shortage"
] | Capsule | Lisdexamfetamine Dimesylate Capsule | hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0372-25 | 07/14/2023 | Hikma Pharmaceuticals USA, Inc. | 0054-0372-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/14/2023", "package_ndc": "0054-0372-25", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Available on allocation" | Current | Psychiatry | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0372-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Available on allocation | Shortage of an active ingredient |
Limited Availability | 1192 | [
"days_in_shortage"
] | Capsule | Lisdexamfetamine Dimesylate Capsule | hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0373-25 | 07/14/2023 | Hikma Pharmaceuticals USA, Inc. | 0054-0373-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/14/2023", "package_ndc": "0054-0373-25", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Available on allocation" | Current | Psychiatry | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0373-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Available on allocation | Shortage of an active ingredient |
Limited Availability | 1192 | [
"days_in_shortage"
] | Capsule | Lisdexamfetamine Dimesylate Capsule | hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0374-25 | 07/14/2023 | Hikma Pharmaceuticals USA, Inc. | 0054-0374-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/14/2023", "package_ndc": "0054-0374-25", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Available on allocation" | Current | Psychiatry | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0374-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Available on allocation | Shortage of an active ingredient |
Limited Availability | 1192 | [
"days_in_shortage"
] | Capsule | Lisdexamfetamine Dimesylate Capsule | hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0375-25 | 07/14/2023 | Hikma Pharmaceuticals USA, Inc. | 0054-0375-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/14/2023", "package_ndc": "0054-0375-25", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Available on allocation" | Current | Psychiatry | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0375-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Available on allocation | Shortage of an active ingredient |
Limited Availability | 1192 | [
"days_in_shortage"
] | Capsule | Lisdexamfetamine Dimesylate Capsule | hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0660-25 | 07/14/2023 | Hikma Pharmaceuticals USA, Inc. | 0054-0660-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/14/2023", "package_ndc": "0054-0660-25", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Available on allocation" | Current | Psychiatry | 05/12/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0660-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Available on allocation | Shortage of an active ingredient |
Available | 201 | [
"days_in_shortage"
] | Oral Solution | Furosemide Oral Solution | hikma-pharmaceuticals-usa-inc-furosemide-oral-solution-0054-3294-46 | 03/31/2026 | Hikma Pharmaceuticals USA, Inc. | 0054-3294-46 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Oral%20Solution%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/31/2026", "package_ndc": "0054-3294-46", "generic_name": "Furosemide Oral Solution", "contact_info": "800-631-2174", "availability": "Available" | Current | Cardiovascular | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-furosemide-oral-solution-0054-3294-46/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Limited Availability | 201 | [
"days_in_shortage"
] | Oral Solution | Furosemide Oral Solution | hikma-pharmaceuticals-usa-inc-furosemide-oral-solution-0054-3294-50 | 03/31/2026 | Hikma Pharmaceuticals USA, Inc. | 0054-3294-50 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Oral%20Solution%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/31/2026", "package_ndc": "0054-3294-50", "generic_name": "Furosemide Oral Solution", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Available on allocation" | Current | Cardiovascular | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-furosemide-oral-solution-0054-3294-50/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Available on allocation | Shortage of an inactive ingredient component |
Available | 201 | [
"days_in_shortage"
] | Oral Solution | Furosemide Oral Solution | hikma-pharmaceuticals-usa-inc-furosemide-oral-solution-0054-3298-63 | 03/31/2026 | Hikma Pharmaceuticals USA, Inc. | 0054-3298-63 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Oral%20Solution%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/31/2026", "package_ndc": "0054-3298-63", "generic_name": "Furosemide Oral Solution", "contact_info": "800-631-2174", "availability": "Available" | Current | Cardiovascular | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-furosemide-oral-solution-0054-3298-63/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | null | Shortage of an inactive ingredient component |
Unavailable | 2069 | [
"days_in_shortage"
] | Injection | Rifampin Injection | sanofi-aventis-u-s-llc-rifampin-injection-0068-0597-01 | 02/17/2021 | Sanofi-Aventis U.S. LLC | 0068-0597-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sanofi-Aventis%20U.S.%20LLC%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/17/2021", "package_ndc": "0068-0597-01", "generic_name": "Rifampin Injection", "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Rifampin%20Injection&st=d", "contact_info": "800-633-1610", "availability": "Unavailable", "related_inf... | Current | Anti-Infective | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/sanofi-aventis-u-s-llc-rifampin-injection-0068-0597-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug |
Available | 1318 | [
"days_in_shortage"
] | Tablet | Clonazepam Tablet | teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-0832-01 | 03/10/2023 | Teva Pharmaceuticals USA, Inc. | 0093-0832-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/10/2023", "package_ndc": "0093-0832-01", "generic_name": "Clonazepam Tablet", "contact_info": "800-545-8800", "availability": "Available" | Current | Neurology | 10/15/2026 | https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-0832-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1318 | [
"days_in_shortage"
] | Tablet | Clonazepam Tablet | teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-0832-05 | 03/10/2023 | Teva Pharmaceuticals USA, Inc. | 0093-0832-05 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/10/2023", "package_ndc": "0093-0832-05", "generic_name": "Clonazepam Tablet", "contact_info": "800-545-8800", "availability": "Available" | Current | Neurology | 10/15/2026 | https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-0832-05/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1318 | [
"days_in_shortage"
] | Tablet | Clonazepam Tablet | teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3212-01 | 03/10/2023 | Teva Pharmaceuticals USA, Inc. | 0093-3212-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/10/2023", "package_ndc": "0093-3212-01", "generic_name": "Clonazepam Tablet", "contact_info": "800-545-8800", "availability": "Available" | Current | Neurology | 10/15/2026 | https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3212-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1318 | [
"days_in_shortage"
] | Tablet | Clonazepam Tablet | teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3212-05 | 03/10/2023 | Teva Pharmaceuticals USA, Inc. | 0093-3212-05 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/10/2023", "package_ndc": "0093-3212-05", "generic_name": "Clonazepam Tablet", "contact_info": "800-545-8800", "availability": "Available" | Current | Neurology | 10/15/2026 | https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3212-05/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1318 | [
"days_in_shortage"
] | Tablet | Clonazepam Tablet | teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3213-01 | 03/10/2023 | Teva Pharmaceuticals USA, Inc. | 0093-3213-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/10/2023", "package_ndc": "0093-3213-01", "generic_name": "Clonazepam Tablet", "contact_info": "800-545-8800", "availability": "Available" | Current | Neurology | 10/01/2026 | https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3213-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1318 | [
"days_in_shortage"
] | Tablet | Clonazepam Tablet | teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3213-05 | 03/10/2023 | Teva Pharmaceuticals USA, Inc. | 0093-3213-05 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/10/2023", "package_ndc": "0093-3213-05", "generic_name": "Clonazepam Tablet", "contact_info": "800-545-8800", "availability": "Available" | Current | Neurology | 10/15/2026 | https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3213-05/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1188 | [
"days_in_shortage"
] | Injection | Liraglutide Injection | hikma-pharmaceuticals-usa-inc-liraglutide-injection-0143-9144-02 | 07/18/2023 | Hikma Pharmaceuticals USA, Inc. | 0143-9144-02 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/18/2023", "package_ndc": "0143-9144-02", "generic_name": "Liraglutide Injection", "contact_info": "800-631-2174", "availability": "Available" | Current | Endocrinology/Metabolism | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-liraglutide-injection-0143-9144-02/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1188 | [
"days_in_shortage"
] | Injection | Liraglutide Injection | hikma-pharmaceuticals-usa-inc-liraglutide-injection-0143-9144-03 | 07/18/2023 | Hikma Pharmaceuticals USA, Inc. | 0143-9144-03 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/18/2023", "package_ndc": "0143-9144-03", "generic_name": "Liraglutide Injection", "contact_info": "800-631-2174", "availability": "Available" | Current | Endocrinology/Metabolism | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-liraglutide-injection-0143-9144-03/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1341 | [
"days_in_shortage"
] | Injection | Rocuronium Bromide Injection | hikma-pharmaceuticals-usa-inc-rocuronium-bromide-injection-0143-9250-10 | 02/15/2023 | Hikma Pharmaceuticals USA, Inc. | 0143-9250-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/15/2023", "package_ndc": "0143-9250-10", "generic_name": "Rocuronium Bromide Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional lots will be available. Product will be made available as it is released." | Current | Anesthesia | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-rocuronium-bromide-injection-0143-9250-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional lots will be available. Product will be made available as it is released. | null |
Available | 1341 | [
"days_in_shortage"
] | Injection | Rocuronium Bromide Injection | hikma-pharmaceuticals-usa-inc-rocuronium-bromide-injection-0143-9251-10 | 02/15/2023 | Hikma Pharmaceuticals USA, Inc. | 0143-9251-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/15/2023", "package_ndc": "0143-9251-10", "generic_name": "Rocuronium Bromide Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional lots will be available. Product will be made available as it is released." | Current | Anesthesia | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-rocuronium-bromide-injection-0143-9251-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional lots will be available. Product will be made available as it is released. | null |
Unavailable | 3268 | [
"days_in_shortage"
] | Injection | Dopamine Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-dopamine-hydrochloride-injection-0143-9252-25 | 11/06/2017 | Hikma Pharmaceuticals USA, Inc. | 0143-9252-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "11/06/2017", "package_ndc": "0143-9252-25", "generic_name": "Dopamine Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Product temporarily on backorder. Additional lots will be available in the February 2027 timeframe." | Current | Cardiovascular | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-dopamine-hydrochloride-injection-0143-9252-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Product temporarily on backorder. Additional lots will be available in the February 2027 timeframe. | Demand increase for the drug |
Unavailable | 3268 | [
"days_in_shortage"
] | Injection | Dopamine Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-dopamine-hydrochloride-injection-0143-9254-25 | 11/06/2017 | Hikma Pharmaceuticals USA, Inc. | 0143-9254-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "11/06/2017", "package_ndc": "0143-9254-25", "generic_name": "Dopamine Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released." | Current | Cardiovascular | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-dopamine-hydrochloride-injection-0143-9254-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released. | Demand increase for the drug |
Available | 1474 | [
"days_in_shortage"
] | Injection | Etomidate Injection | hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9310-10 | 10/05/2022 | Hikma Pharmaceuticals USA, Inc. | 0143-9310-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/05/2022", "package_ndc": "0143-9310-10", "generic_name": "Etomidate Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Novaplus label" | Current | Anesthesia | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9310-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Novaplus label | null |
Available | 1474 | [
"days_in_shortage"
] | Injection | Etomidate Injection | hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9311-10 | 10/05/2022 | Hikma Pharmaceuticals USA, Inc. | 0143-9311-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/05/2022", "package_ndc": "0143-9311-10", "generic_name": "Etomidate Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Novaplus label" | Current | Anesthesia | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9311-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Novaplus label | null |
Unavailable | 1573 | [
"days_in_shortage"
] | Injection | Remifentanil Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-remifentanil-hydrochloride-injection-0143-9391-10 | 06/28/2022 | Hikma Pharmaceuticals USA, Inc. | 0143-9391-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "06/28/2022", "package_ndc": "0143-9391-10", "generic_name": "Remifentanil Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Estimated recovery: TBD" | Current | Analgesia/Addiction | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-remifentanil-hydrochloride-injection-0143-9391-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: TBD | Demand increase for the drug |
Unavailable | 1573 | [
"days_in_shortage"
] | Injection | Remifentanil Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-remifentanil-hydrochloride-injection-0143-9392-10 | 06/28/2022 | Hikma Pharmaceuticals USA, Inc. | 0143-9392-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "06/28/2022", "package_ndc": "0143-9392-10", "generic_name": "Remifentanil Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Estimated recovery: TBD" | Current | Analgesia/Addiction | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-remifentanil-hydrochloride-injection-0143-9392-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: TBD | Demand increase for the drug |
Unavailable | 1573 | [
"days_in_shortage"
] | Injection | Remifentanil Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-remifentanil-hydrochloride-injection-0143-9393-10 | 06/28/2022 | Hikma Pharmaceuticals USA, Inc. | 0143-9393-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "06/28/2022", "package_ndc": "0143-9393-10", "generic_name": "Remifentanil Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Estimated recovery: TBD" | Current | Analgesia/Addiction | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-remifentanil-hydrochloride-injection-0143-9393-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: TBD | Demand increase for the drug |
Available | 1474 | [
"days_in_shortage"
] | Injection | Etomidate Injection | hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9506-10 | 10/05/2022 | Hikma Pharmaceuticals USA, Inc. | 0143-9506-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/05/2022", "package_ndc": "0143-9506-10", "generic_name": "Etomidate Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional product will be made available as it is released." | Current | Anesthesia | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9506-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional product will be made available as it is released. | null |
Available | 1474 | [
"days_in_shortage"
] | Injection | Etomidate Injection | hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9507-10 | 10/05/2022 | Hikma Pharmaceuticals USA, Inc. | 0143-9507-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/05/2022", "package_ndc": "0143-9507-10", "generic_name": "Etomidate Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional product will be made available as it is released." | Current | Anesthesia | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9507-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional product will be made available as it is released. | null |
Unavailable | 1315 | [
"days_in_shortage"
] | Injection | Methotrexate Sodium Injection | hikma-pharmaceuticals-usa-inc-methotrexate-sodium-injection-0143-9519-10 | 03/13/2023 | Hikma Pharmaceuticals USA, Inc. | 0143-9519-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/13/2023", "package_ndc": "0143-9519-10", "generic_name": "Methotrexate Sodium Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released." | Current | Rheumatology | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-methotrexate-sodium-injection-0143-9519-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released. | Demand increase for the drug |
Unavailable | 128 | [
"days_in_shortage"
] | Injection | Ifosfamide Injection | hikma-pharmaceuticals-usa-inc-ifosfamide-injection-0143-9530-01 | 06/12/2026 | Hikma Pharmaceuticals USA, Inc. | 0143-9530-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "06/12/2026", "package_ndc": "0143-9530-01", "generic_name": "Ifosfamide Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released." | Current | Oncology | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-ifosfamide-injection-0143-9530-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released. | Demand increase for the drug |
Unavailable | 128 | [
"days_in_shortage"
] | Injection | Ifosfamide Injection | hikma-pharmaceuticals-usa-inc-ifosfamide-injection-0143-9531-01 | 06/12/2026 | Hikma Pharmaceuticals USA, Inc. | 0143-9531-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "06/12/2026", "package_ndc": "0143-9531-01", "generic_name": "Ifosfamide Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released." | Current | Oncology | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-ifosfamide-injection-0143-9531-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released. | Demand increase for the drug |
Unavailable | 2382 | [
"days_in_shortage"
] | Injection | Dexmedetomidine Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-dexmedetomidine-hydrochloride-injection-0143-9532-25 | 04/10/2020 | Hikma Pharmaceuticals USA, Inc. | 0143-9532-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "04/10/2020", "package_ndc": "0143-9532-25", "generic_name": "Dexmedetomidine Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Product temporarily on backorder. Additional lots will be available in the September 2026 timeframe." | Current | Anesthesia | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-dexmedetomidine-hydrochloride-injection-0143-9532-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Product temporarily on backorder. Additional lots will be available in the September 2026 timeframe. | Demand increase for the drug |
Available | 3049 | [
"days_in_shortage"
] | Injection | Lidocaine Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9575-10 | 06/13/2018 | Hikma Pharmaceuticals USA, Inc. | 0143-9575-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "06/13/2018", "package_ndc": "0143-9575-10", "generic_name": "Lidocaine Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released." | Current | Anesthesia | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9575-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | null |
Available | 3049 | [
"days_in_shortage"
] | Injection | Lidocaine Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9577-10 | 06/13/2018 | Hikma Pharmaceuticals USA, Inc. | 0143-9577-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "06/13/2018", "package_ndc": "0143-9577-10", "generic_name": "Lidocaine Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released." | Current | Anesthesia | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9577-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | null |
Available | 3049 | [
"days_in_shortage"
] | Injection | Lidocaine Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9594-25 | 06/13/2018 | Hikma Pharmaceuticals USA, Inc. | 0143-9594-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "06/13/2018", "package_ndc": "0143-9594-25", "generic_name": "Lidocaine Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released." | Current | Anesthesia | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9594-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | null |
Unavailable | 3049 | [
"days_in_shortage"
] | Injection | Lidocaine Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9595-25 | 06/13/2018 | Hikma Pharmaceuticals USA, Inc. | 0143-9595-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "06/13/2018", "package_ndc": "0143-9595-25", "generic_name": "Lidocaine Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Product temporarily on backorder. Additional lots will be available in the November 2026 timeframe." | Current | Anesthesia | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9595-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Product temporarily on backorder. Additional lots will be available in the November 2026 timeframe. | Demand increase for the drug |
Available | 2130 | [
"days_in_shortage"
] | Injection | Azacitidine Injection | hikma-pharmaceuticals-usa-inc-azacitidine-injection-0143-9606-01 | 12/18/2020 | Hikma Pharmaceuticals USA, Inc. | 0143-9606-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/18/2020", "package_ndc": "0143-9606-01", "generic_name": "Azacitidine Injection", "contact_info": "1-800-631-2174", "availability": "Available", "related_info": "Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released." | Current | Oncology | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-azacitidine-injection-0143-9606-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | null |
Available | 2118 | [
"days_in_shortage"
] | Injection | Valproate Sodium Injection | hikma-pharmaceuticals-usa-inc-valproate-sodium-injection-0143-9785-10 | 12/30/2020 | Hikma Pharmaceuticals USA, Inc. | 0143-9785-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Valproate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/30/2020", "package_ndc": "0143-9785-10", "generic_name": "Valproate Sodium Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional lots will be available. Product will be made available as it is released." | Current | Neurology | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-valproate-sodium-injection-0143-9785-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional lots will be available. Product will be made available as it is released. | null |
Unavailable | 1315 | [
"days_in_shortage"
] | Injection | Methotrexate Sodium Injection | hikma-pharmaceuticals-usa-inc-methotrexate-sodium-injection-0143-9830-01 | 03/13/2023 | Hikma Pharmaceuticals USA, Inc. | 0143-9830-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/13/2023", "package_ndc": "0143-9830-01", "generic_name": "Methotrexate Sodium Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Additional lots will be available in the November 2026 timeframe. Short Dated Prodcut Available." | Current | Rheumatology | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-methotrexate-sodium-injection-0143-9830-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Additional lots will be available in the November 2026 timeframe. Short Dated Prodcut Available. | Demand increase for the drug |
Unavailable | 1083 | [
"days_in_shortage"
] | Injection | Propranolol Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-propranolol-hydrochloride-injection-0143-9872-10 | 10/31/2023 | Hikma Pharmaceuticals USA, Inc. | 0143-9872-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Propranolol%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/31/2023", "package_ndc": "0143-9872-10", "generic_name": "Propranolol Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Estimated recovery: TBD" | Current | Cardiovascular | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-propranolol-hydrochloride-injection-0143-9872-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: TBD | Shortage of an active ingredient |
Unavailable | 4261 | [
"days_in_shortage"
] | Powder, For Solution | Cefotaxime Sodium Powder, for Solution | hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9930-10 | 02/17/2015 | Hikma Pharmaceuticals USA, Inc. | 0143-9930-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/17/2015", "package_ndc": "0143-9930-10", "generic_name": "Cefotaxime Sodium Powder, for Solution", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Estimated recovery: TBD" | Current | Anti-Infective | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9930-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: TBD | Demand increase for the drug |
Unavailable | 4261 | [
"days_in_shortage"
] | Powder, For Solution | Cefotaxime Sodium Powder, for Solution | hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9931-25 | 02/17/2015 | Hikma Pharmaceuticals USA, Inc. | 0143-9931-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/17/2015", "package_ndc": "0143-9931-25", "generic_name": "Cefotaxime Sodium Powder, for Solution", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Estimated recovery: TBD" | Current | Anti-Infective | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9931-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: TBD | Demand increase for the drug |
Unavailable | 4261 | [
"days_in_shortage"
] | Powder, For Solution | Cefotaxime Sodium Powder, for Solution | hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9933-25 | 02/17/2015 | Hikma Pharmaceuticals USA, Inc. | 0143-9933-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/17/2015", "package_ndc": "0143-9933-25", "generic_name": "Cefotaxime Sodium Powder, for Solution", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Estimated recovery: TBD" | Current | Anti-Infective | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9933-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: TBD | Demand increase for the drug |
Unavailable | 4261 | [
"days_in_shortage"
] | Powder, For Solution | Cefotaxime Sodium Powder, for Solution | hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9935-01 | 02/17/2015 | Hikma Pharmaceuticals USA, Inc. | 0143-9935-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/17/2015", "package_ndc": "0143-9935-01", "generic_name": "Cefotaxime Sodium Powder, for Solution", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Estimated recovery: TBD" | Current | Anti-Infective | 10/14/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9935-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: TBD | Demand increase for the drug |
Limited Availability | 1188 | [
"days_in_shortage"
] | Injection | Liraglutide Injection | novo-nordisk-inc-liraglutide-injection-0169-2800-15 | 07/18/2023 | Novo Nordisk, Inc. | 0169-2800-15 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novo%20Nordisk,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/18/2023", "package_ndc": "0169-2800-15", "generic_name": "Liraglutide Injection", "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Liraglutide+Injection&st=d", "contact_info": "833-493-4689", "availability": "Limited Availability",... | Current | Endocrinology/Metabolism | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/novo-nordisk-inc-liraglutide-injection-0169-2800-15/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Product will be available until discontinuation in January 2027 | Discontinuation of the manufacture of the drug |
Limited Availability | 1188 | [
"days_in_shortage"
] | Injection | Liraglutide Injection | novo-nordisk-inc-liraglutide-injection-0169-4060-12 | 07/18/2023 | Novo Nordisk, Inc. | 0169-4060-12 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novo%20Nordisk,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/18/2023", "package_ndc": "0169-4060-12", "generic_name": "Liraglutide Injection", "contact_info": "833-493-4689", "availability": "Limited Availability", "related_info": "Estimated shortage duration: TBD" | Current | Endocrinology/Metabolism | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/novo-nordisk-inc-liraglutide-injection-0169-4060-12/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated shortage duration: TBD | Delay in shipping of the drug |
Limited Availability | 1188 | [
"days_in_shortage"
] | Injection | Liraglutide Injection | novo-nordisk-inc-liraglutide-injection-0169-4060-13 | 07/18/2023 | Novo Nordisk, Inc. | 0169-4060-13 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novo%20Nordisk,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/18/2023", "package_ndc": "0169-4060-13", "generic_name": "Liraglutide Injection", "contact_info": "833-493-4689", "availability": "Limited Availability", "related_info": "Estimated shortage duration: TBD" | Current | Endocrinology/Metabolism | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/novo-nordisk-inc-liraglutide-injection-0169-4060-13/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated shortage duration: TBD | Delay in shipping of the drug |
Available | 1467 | [
"days_in_shortage"
] | Tablet | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-0842-01 | 10/12/2022 | Sandoz Inc. | 0185-0842-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/12/2022", "package_ndc": "0185-0842-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-525-8747", "availability": "Available" | Current | Psychiatry | 10/08/2026 | https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-0842-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1467 | [
"days_in_shortage"
] | Tablet | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-0853-01 | 10/12/2022 | Sandoz Inc. | 0185-0853-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/12/2022", "package_ndc": "0185-0853-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-525-8747", "availability": "Available" | Current | Psychiatry | 10/08/2026 | https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-0853-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1467 | [
"days_in_shortage"
] | Tablet | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-2098-01 | 10/12/2022 | Sandoz Inc. | 0185-2098-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/12/2022", "package_ndc": "0185-2098-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-525-8747", "availability": "Available" | Current | Psychiatry | 10/08/2026 | https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-2098-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1467 | [
"days_in_shortage"
] | Tablet | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-2099-01 | 10/12/2022 | Sandoz Inc. | 0185-2099-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/12/2022", "package_ndc": "0185-2099-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-525-8747", "availability": "Available" | Current | Psychiatry | 10/08/2026 | https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-2099-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1707 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-1510-31 | 02/14/2022 | B. Braun Medical Inc. | 0264-1510-31 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0264-1510-31", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Endocrinology/Metabolism | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-1510-31/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1707 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-1510-32 | 02/14/2022 | B. Braun Medical Inc. | 0264-1510-32 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0264-1510-32", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Endocrinology/Metabolism | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-1510-32/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 2140 | [
"days_in_shortage"
] | Injection | Amino Acid Injection | b-braun-medical-inc-amino-acid-injection-0264-1933-10 | 12/08/2020 | B. Braun Medical Inc. | 0264-1933-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/08/2020", "package_ndc": "0264-1933-10", "generic_name": "Amino Acid Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Gastroenterology | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-amino-acid-injection-0264-1933-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1269 | [
"days_in_shortage"
] | Irrigant | Sterile Water Irrigant | b-braun-medical-inc-sterile-water-irrigant-0264-2101-00 | 04/28/2023 | B. Braun Medical Inc. | 0264-2101-00 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "04/28/2023", "package_ndc": "0264-2101-00", "generic_name": "Sterile Water Irrigant", "company_name": "B. Braun Medical Inc.", "contact_info": "800-227-2862", "availability": "Available" | Current | Gastroenterology | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-sterile-water-irrigant-0264-2101-00/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1269 | [
"days_in_shortage"
] | Irrigant | Sterile Water Irrigant | b-braun-medical-inc-sterile-water-irrigant-0264-2101-10 | 04/28/2023 | B. Braun Medical Inc. | 0264-2101-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "04/28/2023", "package_ndc": "0264-2101-10", "generic_name": "Sterile Water Irrigant", "company_name": "B. Braun Medical Inc.", "contact_info": "800-227-2862", "availability": "Available" | Current | Gastroenterology | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-sterile-water-irrigant-0264-2101-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 2140 | [
"days_in_shortage"
] | Injection | Amino Acid Injection | b-braun-medical-inc-amino-acid-injection-0264-4500-00 | 12/08/2020 | B. Braun Medical Inc. | 0264-4500-00 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/08/2020", "package_ndc": "0264-4500-00", "generic_name": "Amino Acid Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Gastroenterology | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-amino-acid-injection-0264-4500-00/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 2140 | [
"days_in_shortage"
] | Injection | Amino Acid Injection | b-braun-medical-inc-amino-acid-injection-0264-4500-05 | 12/08/2020 | B. Braun Medical Inc. | 0264-4500-05 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/08/2020", "package_ndc": "0264-4500-05", "generic_name": "Amino Acid Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Gastroenterology | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-amino-acid-injection-0264-4500-05/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 737 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 70% Injection | b-braun-medical-inc-dextrose-monohydrate-70-injection-0264-7387-50 | 10/11/2024 | B. Braun Medical Inc. | 0264-7387-50 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2070%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/11/2024", "package_ndc": "0264-7387-50", "generic_name": "Dextrose Monohydrate 70% Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Endocrinology/Metabolism | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-70-injection-0264-7387-50/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1707 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-7510-00 | 02/14/2022 | B. Braun Medical Inc. | 0264-7510-00 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0264-7510-00", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Endocrinology/Metabolism | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-7510-00/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1707 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-7510-10 | 02/14/2022 | B. Braun Medical Inc. | 0264-7510-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0264-7510-10", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Endocrinology/Metabolism | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-7510-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1707 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-7510-20 | 02/14/2022 | B. Braun Medical Inc. | 0264-7510-20 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0264-7510-20", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Endocrinology/Metabolism | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-7510-20/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1692 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 10% Injection | b-braun-medical-inc-dextrose-monohydrate-10-injection-0264-7520-00 | 03/01/2022 | B. Braun Medical Inc. | 0264-7520-00 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/01/2022", "package_ndc": "0264-7520-00", "generic_name": "Dextrose Monohydrate 10% Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Endocrinology/Metabolism | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-10-injection-0264-7520-00/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1692 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 10% Injection | b-braun-medical-inc-dextrose-monohydrate-10-injection-0264-7520-10 | 03/01/2022 | B. Braun Medical Inc. | 0264-7520-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/01/2022", "package_ndc": "0264-7520-10", "generic_name": "Dextrose Monohydrate 10% Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Endocrinology/Metabolism | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-10-injection-0264-7520-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1692 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 10% Injection | b-braun-medical-inc-dextrose-monohydrate-10-injection-0264-7520-20 | 03/01/2022 | B. Braun Medical Inc. | 0264-7520-20 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/01/2022", "package_ndc": "0264-7520-20", "generic_name": "Dextrose Monohydrate 10% Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Endocrinology/Metabolism | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-10-injection-0264-7520-20/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 3280 | [
"days_in_shortage"
] | Injection | Lidocaine Hydrochloride Injection | b-braun-medical-inc-lidocaine-hydrochloride-injection-0264-9594-10 | 10/25/2017 | B. Braun Medical Inc. | 0264-9594-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/25/2017", "package_ndc": "0264-9594-10", "generic_name": "Lidocaine Hydrochloride Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Cardiovascular | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-lidocaine-hydrochloride-injection-0264-9594-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 3280 | [
"days_in_shortage"
] | Injection | Lidocaine Hydrochloride Injection | b-braun-medical-inc-lidocaine-hydrochloride-injection-0264-9594-20 | 10/25/2017 | B. Braun Medical Inc. | 0264-9594-20 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/25/2017", "package_ndc": "0264-9594-20", "generic_name": "Lidocaine Hydrochloride Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Cardiovascular | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-lidocaine-hydrochloride-injection-0264-9594-20/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 3280 | [
"days_in_shortage"
] | Injection | Lidocaine Hydrochloride Injection | b-braun-medical-inc-lidocaine-hydrochloride-injection-0264-9598-20 | 10/25/2017 | B. Braun Medical Inc. | 0264-9598-20 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/25/2017", "package_ndc": "0264-9598-20", "generic_name": "Lidocaine Hydrochloride Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Cardiovascular | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-lidocaine-hydrochloride-injection-0264-9598-20/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Limited Availability | 3260 | [
"days_in_shortage"
] | Injection | Heparin Sodium Injection | b-braun-medical-inc-heparin-sodium-injection-0264-9872-00 | 11/14/2017 | B. Braun Medical Inc. | 0264-9872-00 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "11/14/2017", "package_ndc": "0264-9872-00", "generic_name": "Heparin Sodium Injection", "contact_info": "800-227-2862", "availability": "Limited Availability", "related_info": "Estimated recovery: late Q4 2026; Manufacturing delays" | Current | Hematology | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-heparin-sodium-injection-0264-9872-00/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: late Q4 2026; Manufacturing delays | Other |
Limited Availability | 3260 | [
"days_in_shortage"
] | Injection | Heparin Sodium Injection | b-braun-medical-inc-heparin-sodium-injection-0264-9872-10 | 11/14/2017 | B. Braun Medical Inc. | 0264-9872-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "11/14/2017", "package_ndc": "0264-9872-10", "generic_name": "Heparin Sodium Injection", "contact_info": "800-227-2862", "availability": "Limited Availability", "related_info": "Estimated recovery: late Q4 2026; Manufacturing delays" | Current | Hematology | 10/07/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-heparin-sodium-injection-0264-9872-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: late Q4 2026; Manufacturing delays | Other |
Available | 1269 | [
"days_in_shortage"
] | Irrigant | Sterile Water Irrigant | baxter-healthcare-sterile-water-irrigant-0338-0004-02 | 04/28/2023 | Baxter Healthcare | 0338-0004-02 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "04/28/2023", "package_ndc": "0338-0004-02", "generic_name": "Sterile Water Irrigant", "contact_info": "888-229-0001", "availability": "Available" | Current | Gastroenterology | 10/02/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-sterile-water-irrigant-0338-0004-02/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Limited Availability | 1269 | [
"days_in_shortage"
] | Irrigant | Sterile Water Irrigant | baxter-healthcare-sterile-water-irrigant-0338-0004-03 | 04/28/2023 | Baxter Healthcare | 0338-0004-03 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "04/28/2023", "package_ndc": "0338-0004-03", "generic_name": "Sterile Water Irrigant", "contact_info": "888-229-0001", "availability": "Limited Availability", "related_info": "Estimated Recovery: October 2026" | Current | Gastroenterology | 10/02/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-sterile-water-irrigant-0338-0004-03/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated Recovery: October 2026 | Other |
Available | 1269 | [
"days_in_shortage"
] | Irrigant | Sterile Water Irrigant | baxter-healthcare-sterile-water-irrigant-0338-0004-04 | 04/28/2023 | Baxter Healthcare | 0338-0004-04 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "04/28/2023", "package_ndc": "0338-0004-04", "generic_name": "Sterile Water Irrigant", "contact_info": "888-229-0001", "availability": "Available" | Current | Gastroenterology | 10/02/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-sterile-water-irrigant-0338-0004-04/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1707 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-02 | 02/14/2022 | Baxter Healthcare | 0338-0017-02 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0338-0017-02", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "888-229-0001", "availability": "Available" | Current | Endocrinology/Metabolism | 10/02/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-02/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1707 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-03 | 02/14/2022 | Baxter Healthcare | 0338-0017-03 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0338-0017-03", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "888-229-0001", "availability": "Available" | Current | Endocrinology/Metabolism | 10/02/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-03/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1707 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-10 | 02/14/2022 | Baxter Healthcare | 0338-0017-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0338-0017-10", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "888-229-0001", "availability": "Available" | Current | Endocrinology/Metabolism | 10/02/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Unavailable | 1707 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-11 | 02/14/2022 | Baxter Healthcare | 0338-0017-11 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0338-0017-11", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "888-229-0001", "availability": "Unavailable", "related_info": "Estimated recovery: November 2026" | Current | Endocrinology/Metabolism | 10/02/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-11/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: November 2026 | Demand increase for the drug |
Available | 1707 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-18 | 02/14/2022 | Baxter Healthcare | 0338-0017-18 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0338-0017-18", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "888-229-0001", "availability": "Available" | Current | Endocrinology/Metabolism | 10/02/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-18/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1707 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-31 | 02/14/2022 | Baxter Healthcare | 0338-0017-31 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0338-0017-31", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "888-229-0001", "availability": "Available" | Current | Endocrinology/Metabolism | 10/02/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-31/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1707 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-38 | 02/14/2022 | Baxter Healthcare | 0338-0017-38 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0338-0017-38", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "888-229-0001", "availability": "Available" | Current | Endocrinology/Metabolism | 10/02/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-38/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.